This content is provided by Nishimura & Asahi.
Overview
Our Life Science and Healthcare Group offers a variety of legal services to domestic and international clients, including advising on issues regarding licensing, approvals, notifications, etc., compliance, risk management raised by non-compliance, defective product recalls, and information management and intellectual property rights in the medical field, healthcare field (including food and beverage fields), and the medicine and medical device fields, based on applicable laws such as the Pharmaceuticals Medical Machinery, etc. Act, the Medical Care Act, the Medical Practitioners Act, the Food Sanitation Act, and the Health Promotion Act. In addition, our Life Science and Healthcare Group has undertaken various M&A cases, taking advantage of the group’s broad knowledge, and provided strategic advice. We provide advice on a broad range of cases, including business mergers, joint ventures, acquisitions, and restructuring among pharmaceutical companies and medical device companies. As one example, we have advised Takeda Pharmaceutical Co., Ltd., the largest pharmaceutical company in Asia, on its transaction to acquire all of the issued and to-be-issued ordinary share capital of Shire plc, a Jersey-registered and Dublin, Ireland-headquartered global specialty biopharmaceutical company.
Members
Date, Takahiko
Igaki, Taisuke
Kasai, Yoko
Mimura, Mariko
Oi, Yuki
Shibata, Hiroko
Suzuki, Gaku